AK3280 / Ark Biosci  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AK3280 / Ark Biosci
NCT05424887: A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

Not yet recruiting
2
105
RoW
AK3280, Placebo
Ark Biosciences Inc., Shanghai Ark Biopharmaceutical Co., Ltd.
Idiopathic Pulmonary Fibrosis
07/24
10/24
NCT05434897: A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar

Not yet recruiting
1/2
30
RoW
AK3280 Cream, AK3287, Placebo cream
Ark Biosciences Inc., Shanghai Ark Biopharmaceutical Co., Ltd.
Hypertrophic Scar
07/23
11/23

Download Options